Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$45.13 - $64.99 $22.1 Million - $31.9 Million
-490,432 Closed
0 $0
Q1 2021

Sep 21, 2023

BUY
$29.77 - $84.85 $14.6 Million - $41.6 Million
490,432 New
490,432 $31 Million
Q1 2021

May 14, 2021

BUY
$29.77 - $84.85 $14.6 Million - $41.6 Million
490,432 New
490,432 $31 Million
Q4 2019

Feb 13, 2020

SELL
$13.02 - $19.5 $1.83 Million - $2.74 Million
-140,533 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$17.46 - $29.05 $271,206 - $451,233
15,533 Added 12.43%
140,533 $2.55 Million
Q2 2019

Aug 14, 2019

BUY
$18.0 - $19.82 $2.25 Million - $2.48 Million
125,000 New
125,000 $2.48 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.